Evidence map›Paper›PMID 16555283›Full record

ArticleJournal of medical virology2006

Enhanced identification of viral and atypical bacterial pathogens in lower respiratory tract samples with nucleic acid amplification tests.

Bonita E Lee, Joan L Robinson, Vinod Khurana, Xiaoli L Pang, Jutta K Preiksaitis, Julie D Fox

Open access · bronzeAbstract read
In one paragraph

Article in Journal of medical virology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Epidemiology of respiratory viruses in bronchoalveolar lavage samples in a tertiary hospital.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2014
    Article
  6. Article
  7. Article
  8. Article
  9. Updates in the relationship between human rhinovirus and asthma.Allergy, asthma & immunology research · 2012
    Article
  10. Article
  11. HOPE-BAL: improved molecular diagnostics by application of a novel technique for fixation and paraffin embedding.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2011
    Article
  12. Article
  13. Article
  14. Prospective evaluation of a novel multiplex real-time PCR assay for detection of fifteen respiratory pathogens-duration of symptoms significantly affects detection rate.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2010
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Use of throat swab or saliva specimens for detection of respiratory viruses in children.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2008
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Bonita E LeeProvincial Health Public Laboratory (Microbiology), Alberta, Canada.
Joan L Robinson
Vinod Khurana
Xiaoli L Pang
Jutta K Preiksaitis
Julie D Fox
Provincial Laboratory of Public Health · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The advantages of nucleic acid amplification tests (NAT) over conventional methods for the detection of pathogens in lower respiratory tract samples have not been established. NAT for respiratory pathogens were performed on 439 endotracheal tube (ETT) and bronchoalveolar lavage (BAL) samples. A potential pathogen was detected in 87 samples. Of 22 samples that tested positive by conventional methods, 15 tested positive for the same pathogen by NAT, 1 tested positive for a different pathogen, 2 had co-infections identified only by NAT, and 4 tested negative by NAT. An additional 73 pathogens were detected by NAT in 65 samples including 30 pathogens that were missed by conventional methods (19 adenovirus, 6 respiratory syncytial virus, 3 parainfluenza virus 1-4, 2 influenza A), 41 pathogens not routinely identified by conventional methods in most laboratories (23 rhinovirus, 8 human coronavirus OC43, 5 human metapneumovirus (hMPV), 2 human coronavirus 229E, 2 human coronavirus NL63, 1 Chlamydophila pneumoniae) and 2 pathogens from samples where no respiratory virus testing was requested (1 influenza A, 1 parainfluenza virus). Four of 52 patients who had multiple BAL samples submitted on the same day had negative and positive results by NAT on different samples. NAT improves detection of potential pathogens from ETT and BAL samples.

Indexed as

AdolescentAdultAged, 80 and overBronchiBronchoalveolar LavageChildChild, PreschoolChlamydia InfectionsChlamydophila pneumoniaeDNA, BacterialDNA VirusesHumansInfantIntubation, IntratrachealMiddle AgedNucleic Acid Amplification TechniquesDNA, Bacterial

Identifiers

PMID16555283
PMCPMC7166532
OpenAlexW2124501839

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.